Concepedia

Author

David Farley

Novartis (Switzerland)

Also Known As

D Farley, D. Farley, D. L. Farley, D.L. Farley, DAVID L. FARLEY, Daniel Farley, David FARLEY, David Farley, David L. Farley

41

Publications

1.7K

Citations

15

H-Index

68

Concepts

All Affiliations

Novartis (Switzerland)University of GeorgiaNovartis (United States)Novartis Institutes for BioMedical ResearchUniversity of California San Diego
DF

About

David Farley is an author at Novartis (Switzerland) specializing in medicine, natural sciences, and biochemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

15

1.1K

2

Natural Sciences

11

12

1.1K

3

Biochemistry

9

9

770

4

Engineering

1

1

15

5

Health Sciences

1

1

16

David Farley

×

22

Publications

1.6K

Citations

15

H-Index

YearCitations

Purification, Characterization, and Sequence Analysis of a Potential Virulence Factor from <i>Porphyromonas gingivalis</i> , Peptidylarginine Deiminase

Walker T. McGraw, Jan Potempa, David Farley,

Infection and Immunity

1999

369

Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers

Julien P. N. Papillon, Katsumasa Nakajima, Christopher D. Adair,

Journal of Medicinal Chemistry

2018

225

Molecular cloning of human cathepsin G: structural similarity to mast cell and cytotoxic T lymphocyte proteinases

Guy S. Salvesen, David Farley, Jon D. Shuman,

Biochemistry

1987

211

Linked Deficiencies in Extracellular PPi and Osteopontin Mediate Pathologic Calcification Associated With Defective PC-1 and ANK Expression

Kristen Johnson, James W. Goding, Deborah Van Etten,

Journal of Bone and Mineral Research

2003

198

Identification of Dipeptidyl Nitriles as Potent and Selective Inhibitors of Cathepsin B through Structure-Based Drug Design

Paul D. Greenspan, Kirk Clark, Rubén Tommasi,

Journal of Medicinal Chemistry

2001

136

Finasteride: A slow-binding 5.alpha.-reductase inhibitor

Bernard Faller, David Farley, Hanspeter Nick

Biochemistry

1993

78

One of two chondrocyte‐expressed isoforms of cartilage intermediate‐layer protein functions as an insulin‐like growth factor 1 antagonist

Kristen Johnson, David Farley, Shou‐Ih Hu,

Arthritis & Rheumatism

2003

74

Discovery of Potent, Selective, and Orally Active Carboxylic Acid Based Inhibitors of Matrix Metalloproteinase-13

Lauren G. Monovich, Rubén Tommasi, Roger A. Fujimoto,

Journal of Medicinal Chemistry

2009

56

Arylaminoethyl Amides as Novel Non-Covalent Cathepsin K Inhibitors

Eva Altmann, Johanne Renaud, Jonathan A. Green,

Journal of Medicinal Chemistry

2002

44

cDNA encoding a human homolog of yeast ubiquitin 1

Guy S. Salvesen, Cindy Lloyd, David Farley

Nucleic Acids Research

1987

41

Page 1